search
Back to results

Optimizing Early Enteral Nutrition in Severe Stroke (OPENS)

Primary Purpose

Severe Stroke, Acute Stroke, Dysphagia

Status
Terminated
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
Initial enteral feeding
metoclopramide or mosapride
Sponsored by
Xijing Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Severe Stroke focused on measuring severe stroke, Acute Stroke, Enteral Feeding, Mortality, Disability, Clinical trial

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Severe stroke occurred in 7 days.
  • GCS ≤12 or NIHSS≥11.
  • Any cases of profiles #3 through 5 in Water Swallowing Test or with disorder of consciousness.
  • Plan to receive enteral feeding for at least 7 days.
  • Informed consent.

Exclusion Criteria:

  • Gastrointestinal diseases before stroke, such as gastrointestinal resection, malabsorption,and irritable bowel syndrome.
  • Brain death.
  • Complicated with the disease which only have life expectancy < 6 months in over 50% patients.
  • After cardiac arrest.
  • Received parenteral nutrition support.
  • Pregnant woman.
  • Concurrent severe hepatic or renal dysfunction。
  • Unstable hemodynamics.

Sites / Locations

  • Xijing Hospital
  • Tangdu Hospital
  • The First Affiliated Hospital of Xi'an Jiaotong University,
  • Yulin No.2 Hospital

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Active Comparator

Experimental

Experimental

Arm Label

Full enteral feeding

Modified full enteral feeding

Permissive underfeeding

Arm Description

The caloric goal of the first day is one-third of caloric requirements, the second day is half of caloric requirements, the third day is 70-100% and sustained for 1 week. Protein requirements are calculated at 1.2 to 1.5 g per kilogram of body weight per day.

Consistent with full enteral feeding plan, preventively add metoclopramide or mosapride everyday to improve gastrointestinal (GI) motility.

The caloric goal of the first day is one-third of caloric requirements, the second day is 40-60% and sustained for 1 week. Protein requirements are calculated at 1.2 to 1.5 g per kilogram of body weight per day.

Outcomes

Primary Outcome Measures

Rate of patients with death or major disability (modified Rankin scale score ≥3)
modified Rankin scale score, with score ranging from 0 (normal) to 6 (death), was used to evaluate the functional outcomes after stroke.

Secondary Outcome Measures

Mortality (rate of patients with death)
Rate of patients with death
The scores of National Institute of Health stroke scale
National Institute of Health stroke scale, with scores ranging from 0 (normal function) to 42 (functional impairment)) was used to evaluate the impairment caused by a stroke.
Glasgow Coma Scale
Glasgow Coma Scale, with scores ranging from 3 (no response) to 15 (normal response), was used to grade the conscious state.
modified Rankin scale
modified Rankin scale score, with score ranging from 0 (normal) to 6 (death), was used to evaluate the functional outcomes after stroke.
Barthel index
The Barthel Index is a scale, with score ranging from 0 to 100 (normal), that measures disability or dependence in activities of daily living in stroke patients
modified Rankin scale
modified Rankin scale score, with score ranging from 0 (normal) to 6 (death), was used to evaluate the functional outcomes after stroke.
Barthel index
The Barthel Index is a scale, with score ranging from 0 to 100 (normal), that measures disability or dependence in activities of daily living in stroke patients
The incidence of treatment intolerance
The intolerance including gastric retention, diarrhea, constipation, gastrointestinal hemorrhage
The incidence of serious adverse events
The incidence of adverse events That are related to treatment

Full Information

First Posted
November 27, 2016
Last Updated
October 31, 2021
Sponsor
Xijing Hospital
Collaborators
Tang-Du Hospital, Xi'an Central Hospital, Xi'an Gaoxin Hospital, Yan'an University Affiliated Hospital, The PLA 940 hospital, Xi'an No.3 Hospital, The First Affiliated Hospital of Xi'an Medical University, Yulin No.1 Hospital, The First People's Hospital of Xianyang, Tongchuan Mining Hospital, The PLA General Hospital of Xinjiang, Tongchuan People's Hospital, Yulin No.2 Hospital, First Affiliated Hospital Xi'an Jiaotong University, Ankang Central Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT02982668
Brief Title
Optimizing Early Enteral Nutrition in Severe Stroke
Acronym
OPENS
Official Title
A Multi-center Randomised Controlled Trial to Explore the Ideal Initial Enteral Feeding Strategies in Patients With Severe Stroke at Acute Stage
Study Type
Interventional

2. Study Status

Record Verification Date
December 2020
Overall Recruitment Status
Terminated
Why Stopped
Significantly higher mortality
Study Start Date
January 2017 (Actual)
Primary Completion Date
December 2020 (Actual)
Study Completion Date
December 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Xijing Hospital
Collaborators
Tang-Du Hospital, Xi'an Central Hospital, Xi'an Gaoxin Hospital, Yan'an University Affiliated Hospital, The PLA 940 hospital, Xi'an No.3 Hospital, The First Affiliated Hospital of Xi'an Medical University, Yulin No.1 Hospital, The First People's Hospital of Xianyang, Tongchuan Mining Hospital, The PLA General Hospital of Xinjiang, Tongchuan People's Hospital, Yulin No.2 Hospital, First Affiliated Hospital Xi'an Jiaotong University, Ankang Central Hospital

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this academic lead study is to explore the ideal nutritional support strategy for patient with acute severe stroke.
Detailed Description
Of high mortality and morbidity, severe stroke is associated with devastating damages in neurologic, respiratory, circulatory and many other systems. The outcomes of patients with severe stroke depend largely on medical strategies on acute stage, especially on nutritional support management. Unfortunately, clinical evidence are sparse and the ideal initial feeding strategy remains disputable. The IF-STROKE study aims to provide reliable data on the effects of modified full enteral feeding (target recruitment 200) and permissive underfeeding in patients with acute severe stroke (target recruitment 200) compared to full enteral feeding (target recruitment 200). Patients presenting with acute (<72h) severe stroke (GCS ≦ 12 or NIHSS ≧ 11) and dysphagia (defined by Water Swallowing Test) will be randomly assigned to full enteral feeding, modified full enteral feeding, or permissive underfeeding treatment for 7 days.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Severe Stroke, Acute Stroke, Dysphagia
Keywords
severe stroke, Acute Stroke, Enteral Feeding, Mortality, Disability, Clinical trial

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
306 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Full enteral feeding
Arm Type
Active Comparator
Arm Description
The caloric goal of the first day is one-third of caloric requirements, the second day is half of caloric requirements, the third day is 70-100% and sustained for 1 week. Protein requirements are calculated at 1.2 to 1.5 g per kilogram of body weight per day.
Arm Title
Modified full enteral feeding
Arm Type
Experimental
Arm Description
Consistent with full enteral feeding plan, preventively add metoclopramide or mosapride everyday to improve gastrointestinal (GI) motility.
Arm Title
Permissive underfeeding
Arm Type
Experimental
Arm Description
The caloric goal of the first day is one-third of caloric requirements, the second day is 40-60% and sustained for 1 week. Protein requirements are calculated at 1.2 to 1.5 g per kilogram of body weight per day.
Intervention Type
Other
Intervention Name(s)
Initial enteral feeding
Intervention Type
Drug
Intervention Name(s)
metoclopramide or mosapride
Intervention Description
gastrointestinal (GI) motility improving
Primary Outcome Measure Information:
Title
Rate of patients with death or major disability (modified Rankin scale score ≥3)
Description
modified Rankin scale score, with score ranging from 0 (normal) to 6 (death), was used to evaluate the functional outcomes after stroke.
Time Frame
3 months after enrollment
Secondary Outcome Measure Information:
Title
Mortality (rate of patients with death)
Description
Rate of patients with death
Time Frame
3 months after enrollment
Title
The scores of National Institute of Health stroke scale
Description
National Institute of Health stroke scale, with scores ranging from 0 (normal function) to 42 (functional impairment)) was used to evaluate the impairment caused by a stroke.
Time Frame
7 days after enrollment
Title
Glasgow Coma Scale
Description
Glasgow Coma Scale, with scores ranging from 3 (no response) to 15 (normal response), was used to grade the conscious state.
Time Frame
7 days after enrollment
Title
modified Rankin scale
Description
modified Rankin scale score, with score ranging from 0 (normal) to 6 (death), was used to evaluate the functional outcomes after stroke.
Time Frame
7 days after enrollment
Title
Barthel index
Description
The Barthel Index is a scale, with score ranging from 0 to 100 (normal), that measures disability or dependence in activities of daily living in stroke patients
Time Frame
7 days after enrollment
Title
modified Rankin scale
Description
modified Rankin scale score, with score ranging from 0 (normal) to 6 (death), was used to evaluate the functional outcomes after stroke.
Time Frame
3 months after enrollment
Title
Barthel index
Description
The Barthel Index is a scale, with score ranging from 0 to 100 (normal), that measures disability or dependence in activities of daily living in stroke patients
Time Frame
3 months after enrollment
Title
The incidence of treatment intolerance
Description
The intolerance including gastric retention, diarrhea, constipation, gastrointestinal hemorrhage
Time Frame
7 days after enrollment
Title
The incidence of serious adverse events
Time Frame
3 months after enrollment
Title
The incidence of adverse events That are related to treatment
Time Frame
3 months after enrollment

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Severe stroke occurred in 7 days. GCS ≤12 or NIHSS≥11. Any cases of profiles #3 through 5 in Water Swallowing Test or with disorder of consciousness. Plan to receive enteral feeding for at least 7 days. Informed consent. Exclusion Criteria: Gastrointestinal diseases before stroke, such as gastrointestinal resection, malabsorption,and irritable bowel syndrome. Brain death. Complicated with the disease which only have life expectancy < 6 months in over 50% patients. After cardiac arrest. Received parenteral nutrition support. Pregnant woman. Concurrent severe hepatic or renal dysfunction。 Unstable hemodynamics.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Wen Jiang, PhD
Organizational Affiliation
Department of Neurology, Xijing Hospital, Fourth Military Medical University
Official's Role
Study Director
Facility Information:
Facility Name
Xijing Hospital
City
Xi'an
State/Province
Shaanxi
ZIP/Postal Code
710032
Country
China
Facility Name
Tangdu Hospital
City
Xi'an
State/Province
Shaanxi
ZIP/Postal Code
710038
Country
China
Facility Name
The First Affiliated Hospital of Xi'an Jiaotong University,
City
Xi'an
State/Province
Shaanxi
ZIP/Postal Code
710061
Country
China
Facility Name
Yulin No.2 Hospital
City
Yunlin
State/Province
Shaanxi
ZIP/Postal Code
719000
Country
China

12. IPD Sharing Statement

Citations:
PubMed Identifier
24289189
Citation
Wirth R, Smoliner C, Jager M, Warnecke T, Leischker AH, Dziewas R; DGEM Steering Committee*. Guideline clinical nutrition in patients with stroke. Exp Transl Stroke Med. 2013 Dec 1;5(1):14. doi: 10.1186/2040-7378-5-14.
Results Reference
background
PubMed Identifier
26773077
Citation
McClave SA, Taylor BE, Martindale RG, Warren MM, Johnson DR, Braunschweig C, McCarthy MS, Davanos E, Rice TW, Cresci GA, Gervasio JM, Sacks GS, Roberts PR, Compher C; Society of Critical Care Medicine; American Society for Parenteral and Enteral Nutrition. Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr. 2016 Feb;40(2):159-211. doi: 10.1177/0148607115621863. No abstract available. Erratum In: JPEN J Parenter Enteral Nutr. 2016 Nov;40(8):1200.
Results Reference
background
PubMed Identifier
12750536
Citation
FOOD Trial Collaboration. Poor nutritional status on admission predicts poor outcomes after stroke: observational data from the FOOD trial. Stroke. 2003 Jun;34(6):1450-6. doi: 10.1161/01.STR.0000074037.49197.8C. Epub 2003 May 15.
Results Reference
result
PubMed Identifier
20130154
Citation
Ukleja A. Altered GI motility in critically Ill patients: current understanding of pathophysiology, clinical impact, and diagnostic approach. Nutr Clin Pract. 2010 Feb;25(1):16-25. doi: 10.1177/0884533609357568.
Results Reference
result
PubMed Identifier
15733717
Citation
Dennis MS, Lewis SC, Warlow C; FOOD Trial Collaboration. Effect of timing and method of enteral tube feeding for dysphagic stroke patients (FOOD): a multicentre randomised controlled trial. Lancet. 2005 Feb 26-Mar 4;365(9461):764-72. doi: 10.1016/S0140-6736(05)17983-5.
Results Reference
result
PubMed Identifier
20971534
Citation
Heyland DK, Stephens KE, Day AG, McClave SA. The success of enteral nutrition and ICU-acquired infections: a multicenter observational study. Clin Nutr. 2011 Apr;30(2):148-55. doi: 10.1016/j.clnu.2010.09.011. Epub 2010 Oct 25.
Results Reference
result
PubMed Identifier
22673593
Citation
Jie B, Jiang ZM, Nolan MT, Zhu SN, Yu K, Kondrup J. Impact of preoperative nutritional support on clinical outcome in abdominal surgical patients at nutritional risk. Nutrition. 2012 Oct;28(10):1022-7. doi: 10.1016/j.nut.2012.01.017. Epub 2012 Jun 5.
Results Reference
result
PubMed Identifier
22307571
Citation
National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network; Rice TW, Wheeler AP, Thompson BT, Steingrub J, Hite RD, Moss M, Morris A, Dong N, Rock P. Initial trophic vs full enteral feeding in patients with acute lung injury: the EDEN randomized trial. JAMA. 2012 Feb 22;307(8):795-803. doi: 10.1001/jama.2012.137. Epub 2012 Feb 5.
Results Reference
result
PubMed Identifier
26398094
Citation
Permissive Underfeeding or Standard Enteral Feeding in Critically Ill Adults. N Engl J Med. 2015 Sep 24;373(13):1281. doi: 10.1056/NEJMx150028. No abstract available.
Results Reference
result
PubMed Identifier
35219379
Citation
Zhao J, Yuan F, Song C, Yin R, Chang M, Zhang W, Zhang B, Yu L, Jia Y, Ma Y, Song Y, Wang C, Song C, Wang X, Shang L, Yang F, Jiang W; OPENS Trial Investigators. Safety and efficacy of three enteral feeding strategies in patients with severe stroke in China (OPENS): a multicentre, prospective, randomised, open-label, blinded-endpoint trial. Lancet Neurol. 2022 Apr;21(4):319-328. doi: 10.1016/S1474-4422(22)00010-2. Epub 2022 Feb 24.
Results Reference
derived
PubMed Identifier
30755171
Citation
Yuan F, Yang F, Zhang W, Jia Y, Ma Y, Qu Y, Wang X, Huo K, Wang C, Yuan X, Song C, Zhang B, Jiang W; OPENS study group. Optimizing early enteral nutrition in severe stroke (OPENS): protocol for a multicentre randomized controlled trial. BMC Neurol. 2019 Feb 12;19(1):24. doi: 10.1186/s12883-019-1253-2.
Results Reference
derived

Learn more about this trial

Optimizing Early Enteral Nutrition in Severe Stroke

We'll reach out to this number within 24 hrs